Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Pathology Analysis & Statistics, May 2013 (p50)

You might be interested in: cancer, breast cancer, prostate cancer, more »

» Purchase Premium Reports

1471-1520 of about 5 600 reports
Trelagliptin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Trelagliptin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Trelagliptin (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Trelagliptin (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type ...

  • Industries : Pathology
MediPoint: Hernia Repair - Global Analysis and Market Forecasts

MediPoint: Hernia Repair - Global Analysis and Market Forecasts

  • $ 6 495
  • Industry report
  • July 2013
  • by Global Data

MediPoint: Hernia Repair - Global Analysis and Market Forecasts Summary Dramatic improvements in access to and quality of healthcare in the Asia Pacific region, concurrent with the introduction of next-generation ...

  • Industries : Pathology
  • Countries : World
MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “MK-3102 (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Empagliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Empagliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Empagliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Empagliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Tofogliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Tofogliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Tofogliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Tofogliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Ipragliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Ipragliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Ipragliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Ipragliflozin (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The ...

  • Industries : Pathology
  • Countries : Japan, World, Brazil, Spain, Italy, France, Germany, India, China, United States, United Kingdom, Europe
Fasiglifam (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Fasiglifam (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Fasiglifam (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Fasiglifam (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
LY2409021 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

LY2409021 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

LY2409021 (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “LY2409021 (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
LY2605541 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

LY2605541 (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

LY2605541 (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “LY2605541 (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Victoza (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Victoza (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Victoza (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Victoza (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Tradjenta (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Tradjenta (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Tradjenta (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Tradjenta (Type 2 Diabetes) - Forecast and Market Analysis to 2022". The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
Tresiba (Type 2 Diabetes) - Forecast and Market Analysis to 2022

Tresiba (Type 2 Diabetes) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Company report
  • July 2013
  • by Global Data

Tresiba (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Tresiba (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes ...

  • Industries : Pathology
  • Countries : World, Brazil, Spain, Italy, France, Germany, Japan, India, China, United States, United Kingdom, Europe
PharmaPoint: Alzheimer's Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Alzheimer's Disease - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • July 2013
  • by Global Data

PharmaPoint: Alzheimer's Disease - Global Drug Forecast and Market Analysis to 2022 Summary There are no long-term effective therapies for Alzheimer's Disease (AD), so this remains at the top of the list ...

  • Industries : Pathology
  • Countries : World
PharmaPoint: Alzheimer's Disease - Current and Future Players

PharmaPoint: Alzheimer's Disease - Current and Future Players

  • $ 2 995
  • Industry report
  • July 2013
  • by Global Data

PharmaPoint: Alzheimer's Disease - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Alzheimer's Disease - Current and Future Players”. The report is a vital ...

  • Industries : Pathology
  • Countries : World
Lixte Biotechnology Holdings, Inc. (LIXT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Lixte Biotechnology Holdings, Inc. (LIXT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Lixte Biotechnology Holdings, Inc. (Lixte) is a research based cancer therapeutics and diagnostics company with focus on the development of improved treatments of human cancers. The company develops ...

  • Industries : Pathology
  • Countries : United States
Cancer Treatment Centers of America - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cancer Treatment Centers of America - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Cancer Treatment Centers of America is engaged in providing comprehensive, patient-centered treatment facilities. It operates cancer treatment hospitals and outpatient clinics and offers medical ...

  • Industries : Pathology
Challenges and Opportunities: in the Renal Denervation Market

Challenges and Opportunities: in the Renal Denervation Market

  • $ 1 689
  • Industry report
  • July 2013
  • by Espicom Business Intelligence

Hypertension: Prevalence and Significance Hypertension is one of the most preventable causes of premature morbidity and mortality globally. It is a major risk factor for stroke, myocardial infarction, ...

  • Industries : Pathology
  • Countries : Japan, United States, World
Europe Ophthalmic Surgical Procedure Volumes - 2013

Europe Ophthalmic Surgical Procedure Volumes - 2013

  • $ 1 599
  • Industry report
  • July 2013
  • by Quomeda Ltd

Europe Ophthalmic Procedures Volumes 2013 is a report adaptation of Quomeda's most recent Surgical Procedures Volumes Database and includes procedure numbers available as a dataset and coded into a unique ...

  • Industries : Pathology
  • Countries : Europe
Eli Lilly and Company (LLY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Eli Lilly and Company (LLY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Eli Lilly and Company (Lilly) is a US based innovation driven pharmaceutical company involved in the discovery, development, manufacturing, and marketing of products. The company's product portfolio ...

  • Industries : Pathology
  • Countries : Canada, World, United States
NeuroSearch AS (MYMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NeuroSearch AS (MYMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary NeuroSearch A/S (NeuroSearch) is a biopharmaceutical company that develops novel pharmaceutical agents for the treatment of various life threatening diseases. It mainly focuses on finding treatment ...

  • Industries : Pathology
Vifor Pharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vifor Pharma AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Vifor Pharma AG (Vifor Pharma) is a pharmaceuticals company. The company discovers, develops and manufactures prescription and over-the-counter (OTC) pharmaceuticals in the areas of renal and infectious ...

  • Industries : Pathology
  • Countries : Switzerland
Incyte Corporation (INCY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Incyte Corporation (INCY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Incyte Corporation (Incyte) is a biopharmaceutical company. It discovers and develops small molecules for the treatment of serious disorders in the field of oncology, inflammation and diabetes. ...

  • Industries : Pathology
  • Countries : United States
Ipsen S.A. (IPN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ipsen S.A. (IPN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Ipsen S.A. (Ipsen) is a specialty-driven pharmaceutical company. The company develops and markets drugs and therapeutic products. It provides specialty care drugs related to the areas of uro-oncology, ...

  • Industries : Pathology
  • Countries : United States
ISA Pharmaceuticals B.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ISA Pharmaceuticals B.V. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary ISA Pharmaceuticals B.V. (ISA) is a biopharmaceutical company. The company designs and develops therapeutic vaccines for cancer and infectious diseases. Its products under clinical development ...

  • Industries : Pathology
Intrexon Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Intrexon Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Intrexon Corporation (Intrexon) is a biotechnology company. The company develops solutions for current and looming challenges. Intrexon's divisions include human therapeutics, protein production, ...

  • Industries : Pathology
  • Countries : United States
NeuroNova AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NeuroNova AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary NeuroNova AB (NeuroNova) is a biopharmaceutical company. The company develops and commercializes therapeutic drugs for the treatment of neurological disorders. Its products include sNN0029 fo ...

  • Industries : Pathology
MSD K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

MSD K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary MSD K.K. (MSD) is a pharmaceutical company. The company develops, manufactures and markets pharmaceuticals products used in healthcare markets. It products include mk-8237, mk-7243, mk-05248, anacetrapi ...

  • Industries : Pathology
Solagran Limited (SLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Solagran Limited (SLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Solagran Limited (Solagran), formerly known as Solagran International is a biotechnology company. It undertakes research and development, and commercialization of natural and biologically active ...

  • Industries : Pathology
NewLink Genetics Corporation (NVLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

NewLink Genetics Corporation (NVLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary NewLink Genetics Corporation (NewLink) is a late-stage biopharmaceutical company. It identifies, develops and commercializes immunotherapeutic products for the treatment of cancer. NewLink's product ...

  • Industries : Pathology
Vertex Pharmaceuticals Incorporated (VRTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vertex Pharmaceuticals Incorporated (VRTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Vertex Pharmaceuticals Incorporated (Vertex) is a biopharmaceutical company. The company carries out the discovery, development and commercialization of small molecule drugs for the treatment of ...

  • Industries : Pathology
  • Countries : United States

» View Public Reports

About 12 000 reports

U.S. Pharmaceutical Industry Analysis

  • Industry report
  • April 2014
  • 129 pages

... Of work are implicated as important causes of hypertension, as well as cvd., E.G. Job strain 96 schnall pl et al. Why the workplace and cardiovascular disease. In: schnall pl, belkic kl, landsbergis pa ...


» Read our Company Profiles

About 200 Companies

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

Johnson and Johnson

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.